Cargando…
Advances in treating glioblastoma
Glioblastoma is the most common and most aggressive primary brain tumor in adults. Optimized standard treatment only confers a modest improvement in progression and overall survival, underscoring the pressing need for the development of novel therapies. Our understanding of glioblastoma (a molecular...
Autores principales: | Weathers, Shiao-Pei, Gilbert, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047946/ https://www.ncbi.nlm.nih.gov/pubmed/24991423 http://dx.doi.org/10.12703/P6-46 |
Ejemplares similares
-
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2023) -
Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015) -
Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews
por: Acquaye, Alvina A., et al.
Publicado: (2019) -
Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging
por: Soni, Vikram S., et al.
Publicado: (2019) -
Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma
por: Cruz, Nuno, et al.
Publicado: (2023)